| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of PFKP mRNA" | 20453058 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of PFKP mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of PFKP mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PFKP mRNA | 15084756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of PFKP protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of PFKP mRNA | 22100608|2715375 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of PFKP mRNA | 19770486 |
| D000452 | Aldrin | Aldrin results in decreased expression of PFKP mRNA | 18579281 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of PFKP mRNA | 28522335 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PFKP mRNA | 16483693 |
| D034341 | Aristolochic Acids | Aristolochic Acids results in increased expression of PFKP mRNA | 19717638 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PFKP protein | 25419056 |
| D001280 | Atrazine | Atrazine results in decreased expression of PFKP mRNA | 25929836 |
| C406592 | azaspiracid | azaspiracid results in increased expression of PFKP mRNA | 28939011 |
| C547126 | AZM551248 | AZM551248 results in increased expression of PFKP mRNA | 22323515 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PFKP mRNA | 20106945 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PFKP mRNA | 19770486 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PFKP mRNA | 25566086 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PFKP mRNA] | 25566086 |
| C044887 | beta-methylcholine | beta-methylcholine affects the expression of PFKP mRNA | 21179406 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PFKP mRNA | 25047013 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PFKP mRNA | 12075121|2518105 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA | 28628672 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of PFKP mRNA | 15003993 |
| C037123 | cadmium sulfate | cadmium sulfate results in increased expression of PFKP mRNA | 19274763 |
| C055494 | caffeic acid phenethyl ester | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PFKP mRNA | 20360939 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of PFKP mRNA | 17484886 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of PFKP mRNA | 23650126 |
| C100187 | chloropicrin | chloropicrin results in increased expression of PFKP mRNA | 26352163 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA | 20938992 |
| D002994 | Clofibrate | Clofibrate results in increased expression of PFKP mRNA | 17585979 |
| D003022 | Clotrimazole | Clotrimazole affects the localization of PFKP protein | 12126931 |
| D003024 | Clozapine | Clozapine results in increased expression of PFKP mRNA | 15860345 |
| D060729 | Coal Ash | Coal Ash results in decreased expression of PFKP mRNA | 19000753 |
| D003300 | Copper | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFKP mRNA | 15467011 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of PFKP mRNA | 19549813 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of PFKP mRNA | 18579281 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PFKP mRNA | 20106945|2556210 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of PFKP mRNA | 21198554 |
| D017485 | 1-Deoxynojirimycin | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein] | 25446853 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA | 28628672 |
| D003976 | Diazinon | Diazinon results in increased methylation of PFKP gene | 22964155 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of PFKP mRNA | 21266533 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of PFKP mRNA | 17379624|2126653 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of PFKP mRNA | 21266533 |
| D002945 | Cisplatin | PFKP protein affects the susceptibility to Cisplatin | 16217747 |
| D004041 | Dietary Fats | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein] | 25446853 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein | 25446853 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of PFKP mRNA | 18042831 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PFKP mRNA | 20360939 |
| C042080 | diisodecyl phthalate | diisodecyl phthalate results in increased expression of PFKP mRNA | 25270620 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of PFKP mRNA | 25380136 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of PFKP mRNA | 19915844 |
| D004317 | Doxorubicin | Razoxane inhibits the reaction [Doxorubicin results in increased expression of PFKP mRNA] | 19915844 |
| D004726 | Endosulfan | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PFKP mRNA | 26159488 |
| C118739 | entinostat | entinostat results in increased expression of PFKP mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of PFKP mRNA | 12075121 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of PFKP mRNA | 23649840 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA | 20938992 |
| D005557 | Formaldehyde | Formaldehyde results in decreased expression of PFKP mRNA | 23649840 |
| D019833 | Genistein | Genistein results in increased expression of PFKP mRNA | 12075121 |
| D005839 | Gentamicins | Gentamicins results in increased expression of PFKP mRNA | 22061828 |
| D005944 | Glucosamine | Glucosamine results in increased expression of PFKP mRNA | 17178593 |
| D006220 | Haloperidol | Haloperidol results in increased expression of PFKP mRNA | 15860345 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of PFKP mRNA | 21396975 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA | 28628672 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PFKP mRNA | 25613284 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA | 28628672 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of PFKP mRNA | 23086925 |
| D007657 | Ketone Bodies | Ketone Bodies results in increased expression of PFKP mRNA | 16807920 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PFKP mRNA | 25613284 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of PFKP mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of PFKP mRNA | 23179753|2718838 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of PFKP mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of PFKP mRNA | 23649840 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PFKP mRNA" | 28087314 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in decreased expression of PFKP mRNA | 25270620 |
| D008777 | Methyltestosterone | Methyltestosterone results in increased expression of PFKP mRNA | 29191790 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of PFKP mRNA | 25380136 |
| D009532 | Nickel | Nickel results in increased expression of PFKP mRNA | 24768652|2558310 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of PFKP mRNA | 19717638 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of PFKP mRNA | 17762391 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of PFKP mRNA | 20042640 |
| D010100 | Oxygen | Oxygen deficiency affects the expression of PFKP mRNA | 17193925 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of PFKP mRNA | 20880076 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of PFKP mRNA | 18042831 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of PFKP mRNA | 26272509 |
| D010269 | Paraquat | Paraquat results in decreased expression of PFKP mRNA | 21371552 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA" | 25510870 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of PFKP mRNA | 26272509 |
| D010852 | Picrotoxin | Picrotoxin results in decreased expression of PFKP mRNA | 15170462 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of PFKP mRNA | 17426115 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of PFKP mRNA | 20813756 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of PFKP mRNA | 19162173 |
| D011134 | Polysaccharides | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein] | 25446853 |
| D011794 | Quercetin | Quercetin results in increased expression of PFKP mRNA | 19729006|2163298 |
| C502851 | quinocetone | quinocetone results in decreased expression of PFKP mRNA | 27046791 |
| D011929 | Razoxane | Razoxane inhibits the reaction [Doxorubicin results in increased expression of PFKP mRNA] | 19915844 |
| C059514 | resveratrol | resveratrol results in increased expression of PFKP protein | 25505154 |
| D012524 | Sarin | Sarin results in decreased expression of PFKP mRNA | 19522546 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of PFKP mRNA | 25895662 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of PFKP protein | 28918527 |
| D013311 | Streptozocin | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein] | 25446853 |
| D013311 | Streptozocin | [Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein | 25446853 |
| D000952 | Antigens, Polyomavirus Transforming | "Antigens, Polyomavirus Transforming results in increased expression of PFKP mRNA" | 26680231 |
| D015085 | 2,4,5-Trichlorophenoxyacetic Acid | "2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of PFKP mRNA" | 18579281 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of PFKP mRNA | 15507505 |
| D013749 | Tetrachlorodibenzodioxin | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PFKP mRNA | 26159488 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA | 20106945|2163298 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PFKP mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PFKP gene] | 20819909 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PFKP mRNA | 19770486 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA | 20819909 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA | 20959002 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in increased expression of PFKP mRNA | 28973375 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PFKP mRNA | 25613284 |
| D019284 | Thapsigargin | Thapsigargin results in decreased expression of PFKP mRNA | 22378314 |
| D013849 | Thimerosal | Thimerosal results in decreased expression of PFKP mRNA | 27188386 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of PFKP mRNA | 28065790 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PFKP mRNA | 16604517 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PFKP mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PFKP mRNA | 15901671 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of PFKP mRNA | 19042947 |
| C013320 | tris(2-butoxyethyl) phosphate | tris(2-butoxyethyl) phosphate affects the expression of PFKP mRNA | 29024780 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of PFKP mRNA | 22378314 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of PFKP mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PFKP mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of PFKP gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PFKP mRNA | 19136453|2054688 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of PFKP mRNA | 15901671 |
| D014639 | Vanadium | Vanadium results in decreased expression of PFKP mRNA | 19000753 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of PFKP gene | 25560391 |
| D014752 | Vinyl Chloride | Vinyl Chloride results in decreased expression of PFKP mRNA | 18579281 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of PFKP mRNA | 26682919 |
| D014810 | Vitamin E | Vitamin E results in increased expression of PFKP mRNA | 19244175 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in decreased expression of PFKP mRNA | 25270620 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of PFKP mRNA | 26272509 |